Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Hwang

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Surgical Pathology Clinics|November 19, 2018
Genitourinary Pathology Reporting Parameters Most Relevant to the Medical OncologistClara Hwang
Therapeutic Advances in Medical Oncology|November 3, 2012
Overcoming docetaxel resistance in prostate cancer: a perspective reviewClara Hwang
Journal of Hematology & Oncology|August 4, 2010
Angiogenesis inhibitors in the treatment of prostate cancerClara Hwang, Elisabeth I Heath
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to G. Procopio et alClara Hwang, Elisabeth I Heath
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
The Judgment of Paris: treatment dilemmas in advanced renal cell carcinomaClara Hwang, Elisabeth I Heath
The Prostate|June 23, 2019
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamideAmanda B Pilling, Clara Hwang
The Prostate|October 21, 2021
Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancerAmanda Pilling, Sahn-Ho Kim, Clara Hwang
Digestive Diseases and Sciences|April 28, 2006
A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitisColleen Schmitt, Charles J Lightdale, Clara Hwang, et al.
Digestive Diseases and Sciences|June 15, 2006
A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitisCharles J Lightdale, Colleen Schmitt, Clara Hwang, et al.
Frontiers in Oncology|March 13, 2026
Body mass index and prostate cancer incidence: a comprehensive systematic reviewDawson Myers, Daniela Chissum Lagos, Isain Zapata, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Surgical Pathology Clinics|November 19, 2018
Genitourinary Pathology Reporting Parameters Most Relevant to the Medical OncologistClara Hwang
Therapeutic Advances in Medical Oncology|November 3, 2012
Overcoming docetaxel resistance in prostate cancer: a perspective reviewClara Hwang
Journal of Hematology & Oncology|August 4, 2010
Angiogenesis inhibitors in the treatment of prostate cancerClara Hwang, Elisabeth I Heath
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to G. Procopio et alClara Hwang, Elisabeth I Heath
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
The Judgment of Paris: treatment dilemmas in advanced renal cell carcinomaClara Hwang, Elisabeth I Heath
The Prostate|June 23, 2019
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamideAmanda B Pilling, Clara Hwang
The Prostate|October 21, 2021
Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancerAmanda Pilling, Sahn-Ho Kim, Clara Hwang
Digestive Diseases and Sciences|April 28, 2006
A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitisColleen Schmitt, Charles J Lightdale, Clara Hwang, et al.
Digestive Diseases and Sciences|June 15, 2006
A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitisCharles J Lightdale, Colleen Schmitt, Clara Hwang, et al.
Frontiers in Oncology|March 13, 2026
Body mass index and prostate cancer incidence: a comprehensive systematic reviewDawson Myers, Daniela Chissum Lagos, Isain Zapata, et al.
Pageof 9